|
HMMR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.487000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.483800E-01 |
| Normal-vs-Stage2 |
9.512100E-02 |
| Normal-vs-Stage3 |
3.377000E-01 |
| Normal-vs-Stage4 |
9.406800E-01 |
| Stage1-vs-Stage2 |
2.034800E-04 |
| Stage1-vs-Stage3 |
1.389780E-01 |
| Stage1-vs-Stage4 |
7.084200E-01 |
| Stage2-vs-Stage3 |
1.003850E-01 |
| Stage2-vs-Stage4 |
2.064400E-02 |
| Stage3-vs-Stage4 |
2.090600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.380200E-01 |
| Normal-vs-AfricanAmerican |
2.476800E-01 |
| Normal-vs-Asian |
5.027800E-01 |
| Caucasian-vs-AfricanAmerican |
1.196560E-01 |
| Caucasian-vs-Asian |
4.339800E-01 |
| AfricanAmerican-vs-Asian |
3.962000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.389800E-01 |
| Normal-vs-Female |
5.237400E-01 |
| Male-vs-Female |
6.951000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.848600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.726010E-01 |
| Normal-vs-Age(61-80Yrs) |
5.550400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.406600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.788600E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.648200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.791400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.586240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.181210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.850180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.901000E-01 |
| Classical-VS-Follicular |
2.102600E-03 |
| Classical-VS-Other |
1.974450E-01 |
| Classical-VS-Normal |
7.871400E-01 |
| Tall-VS-Follicular |
3.850000E-02 |
| Tall-VS-Other |
2.556800E-01 |
| Tall-VS-Normal |
9.496600E-01 |
| Follicular-VS-Other |
7.378800E-01 |
| Follicular-VS-Normal |
1.144610E-01 |
| Other-VS-Normal |
2.968600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.583800E-01 |
| Normal-vs-N1 |
5.407800E-01 |
| N0-vs-N1 |
6.535200E-01 |
|
|
